• This record comes from PubMed

Effect of sphingosine-1-phosphate on L-type calcium current and Ca(2+) transient in rat ventricular myocytes

. 2016 Aug ; 419 (1-2) : 83-92. [epub] 20160702

Language English Country Netherlands Media print-electronic

Document type Journal Article

Grant support
G1002647 Medical Research Council - United Kingdom
PG/11/59/29006 British Heart Foundation - United Kingdom
PG/12/21/29473 British Heart Foundation - United Kingdom
PG/14/80/31106 British Heart Foundation - United Kingdom

Links

PubMed 27372350
DOI 10.1007/s11010-016-2752-8
PII: 10.1007/s11010-016-2752-8
Knihovny.cz E-resources

Modulation of Ca(2+) homoeostasis in cardiac myocytes plays a major role in beat-to-beat regulation of heart function. Previous studies suggest that sphingosine-1-phosphate (S1P), a biologically active sphingomyelin metabolite, regulates Ca(2+) handling in cardiac myocytes, but the underlying mechanism is unclear. In the present study, we tested the hypothesis that S1P-induced functional alteration of intracellular Ca(2+) handling includes the L-type calcium channel current (ICa,L) via a signalling pathway involving P21-activated kinase 1 (Pak1). Our results show that, in rat ventricular myocytes, S1P (100 nM) does not affect the basal activity of ICa,L but is able to partially reverse the effect of the β-adrenergic agonist Isoproterenol (ISO, 100 nM) on ICa,L. S1P (25 nM) also significantly prevents ISO (5 nM)-induced Ca(2+) waves and diastolic Ca(2+) release in these cells. Our further molecular characterisation demonstrates that Pak1 activity is increased in myocytes treated with S1P (25 nM) compared with those myocytes without treatment of S1P. By immunoprecipitation we demonstrate that Pak1 and protein phosphatase 2A (PP2A) are associated in ventricular tissue indicating their functional interaction. Thus the results indicate that S1P attenuates β-adrenergic stress-induced alteration of intracellular Ca(2+) release and L-type Ca(2+) channel current at least in part via Pak1-PP2A-mediated signalling.

See more in PubMed

J Biol Chem. 1997 Feb 21;272(8):4836-42 PubMed

Pharmacol Rev. 2000 Sep;52(3):375-414 PubMed

Genomics. 1998 Oct 15;53(2):164-9 PubMed

Gene. 1999 Feb 4;227(1):89-99 PubMed

J Cell Sci. 2004 Sep 1;117(Pt 19):4343-54 PubMed

Cardiovasc Res. 2009 May 1;82(2):193-200 PubMed

Cell. 2007 Jan 26;128(2):341-55 PubMed

J Biol Chem. 2001 Sep 7;276(36):33697-704 PubMed

Circ Res. 2007 May 11;100(9):1317-27 PubMed

Mol Pharmacol. 2000 Aug;58(2):449-54 PubMed

Biochem J. 2000 Jul 15;349(Pt 2):385-402 PubMed

Cancer Res. 2003 Sep 1;63(17):5446-53 PubMed

Pflugers Arch. 1999 Oct;438(5):642-8 PubMed

FEBS Lett. 2002 Oct 30;531(1):54-7 PubMed

J Clin Invest. 2000 Oct;106(8):951-61 PubMed

Annu Rev Biochem. 2003;72:743-81 PubMed

Am J Physiol Heart Circ Physiol. 2003 Aug;285(2):H735-44 PubMed

J Biol Chem. 1999 Jul 2;274(27):18997-9002 PubMed

Am J Physiol Cell Physiol. 2009 Jan;296(1):C47-58 PubMed

Biochim Biophys Acta. 2004 Jun 1;1682(1-3):48-55 PubMed

Biochem Biophys Res Commun. 1999 Jun 24;260(1):203-8 PubMed

Front Physiol. 2015 Mar 17;6:76 PubMed

Biochem Soc Trans. 2003 Dec;31(Pt 6):1216-9 PubMed

J Histochem Cytochem. 2002 May;50(5):661-70 PubMed

J Biol Chem. 2000 May 12;275(19):14281-6 PubMed

Br J Pharmacol. 2003 Dec;140(7):1163-8 PubMed

Eur J Biochem. 2000 Sep;267(18):5679-86 PubMed

Am J Physiol Heart Circ Physiol. 2011 Oct;301(4):H1487-95 PubMed

J Mol Cell Cardiol. 2010 Feb;48(2):406-14 PubMed

Circ Res. 2004 Feb 6;94(2):194-200 PubMed

Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H736-49 PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...